Caenorhabditis elegans neuromuscular junction: GABA receptors and ivermectin action

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Hernando, Guillermina ^a   Bouzat, Cecilia ^a  

^a Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; IVERMECTIN; LEVAMISOLE; MUSCIMOL; NICOTINIC RECEPTOR; PIPERAZINE; ANTIPARASITIC AGENT; CAENORHABDITIS ELEGANS PROTEIN;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CAENORHABDITIS ELEGANS; CELL MOTILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTROPHYSIOLOGY; GENE; LARVAL STAGE; MATHEMATICAL COMPUTING; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PLEIOTROPY; UNC 49 GENE; ANIMAL; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

ANIMALS; ANTIPARASITIC AGENTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; HUMANS; IVERMECTIN; NEUROMUSCULAR JUNCTION; RECEPTORS, GABA; SYNAPTIC TRANSMISSION;

EID: 84899669008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095072     Document Type: Article

References (59)

1. Sigel E, Steinmann ME (2012) Structure, Function, and Modulation of GABAA Receptors. J Biol Chem 287: 40224-40231.
2. Schuske K, Beg AA, Jorgensen EM (2004) The GABA nervous system in C. elegans. Trends Neurosci 27: 407-414.
3. Sancar F, Czajkowski C (2011) Allosteric modulators induce distinct movements at the GABA-binding site interface of the GABA-A receptor. Neuropharmacology 60: 520-528.
4. Akk G, Steinbach JH (2011) Structural studies of the actions of anesthetic drugs on the gamma-aminobutyric acid type A receptor. Anesthesiology 115: 1338-1348.
5. Accardi MV, Beech RN, Forrester SG (2012) Nematode cys-loop GABA receptors: biological function, pharmacology and sites of action for anthelmintics. Invert Neurosci 12: 3-12.
6. Bartos M, Corradi J, Bouzat C (2009) Structural Basis of Activation of Cys-Loop Receptors: the Extracellular-Transmembrane Interface as a Coupling Region. Mol Neurobiol. 40: 236-252
7. Miller PS, Smart TG (2010) Binding, activation and modulation of Cys-loop receptors. Trends Pharmacol Sci 31: 161-174.
8. Bouzat C (2012) New insights into the structural bases of activation of Cys-loop receptors. J Physiol Paris 106: 23-33.
9. Bamber BA, Richmond JE, Otto JF, Jorgensen EM (2005) The composition of the GABA receptor at the Caenorhabditis elegans neuromuscular junction. Br J Pharmacol 144: 502-509.
10. McIntire SL, Jorgensen E, Kaplan J, Horvitz HR (1993) The GABAergic nervous system of Caenorhabditis elegans. Nature 364: 337-341.
11. Petzold BC, Park SJ, Ponce P, Roozeboom C, Powell C, et al. (2011) Caenorhabditis elegans body mechanics are regulated by body wall muscle tone. Biophys J 100: 1977-1985.
12. Siddiqui SZ, Brown DD, Rao VT, Forrester SG (2010) An UNC-49 GABA receptor subunit from the parasitic nematode Haemonchus contortus is associated with enhanced GABA sensitivity in nematode heteromeric channels. J Neurochem 113: 1113-1122.
13. Williamson SM, Walsh TK, Wolstenholme AJ (2007) The cys-loop ligand-gated ion channel gene family of Brugia malayi and Trichinella spiralis: a comparison with Caenorhabditis elegans. Invert Neurosci 7: 219-226.
14. Martin RJ (1985) gamma-Aminobutyric acid-and piperazine-activated singlechannel currents from Ascaris suum body muscle. Br J Pharmacol 84: 445-461.
15. Lynagh T, Lynch JW (2012) Ivermectin binding sites in human and invertebrate Cys-loop receptors. Trends Pharmacol Sci 33: 432-441.
16. Bamber BA, Beg AA, Twyman RE, Jorgensen EM (1999) The Caenorhabditis elegans unc-49 locus encodes multiple subunits of a heteromultimeric GABA receptor. J Neurosci 19: 5348-5359.
17. Dent JA, Smith MM, Vassilatis DK, Avery L (2000) The genetics of ivermectin resistance in Caenorhabditis elegans. Proc Natl Acad Sci U S A 97: 2674-2679.
18. Rayes D, Flamini M, Hernando G, Bouzat C (2007) Activation of single nicotinic receptor channels from Caenorhabditis elegans muscle. Mol Pharmacol 71: 1407-1415.
19. Hernando G, Bergé I, Rayes D, Bouzat C (2012) Contribution of subunits to Caenorhabditis elegans levamisole-sensitive nicotinic receptor function. Mol Pharmacol 82: 550-560.
20. Almedom RB, Liewald JF, Hernando G, Schultheis C, Rayes D, et al. (2009) An ER-resident membrane protein complex regulates nicotinic acetylcholine receptor subunit composition at the synapse. EMBO J 28: 2636-2649.
21. Christensen M, Estevez A, Yin X, Fox R, Morrison R, et al. (2002) A primary culture system for functional analysis of C. elegans neurons and muscle cells. Neuron 33: 503-514.
22. Rayes D, Spitzmaul G, Sine SM, Bouzat C (2005) Single-channel kinetic analysis of chimeric alpha7-5HT3A receptors. Mol Pharmacol 68: 1475-1483.
23. Liu Y, Dilger JP (1991) Opening rate of acetylcholine receptor channels. Biophys J 60: 424-432.
24. Andersen N, Corradi J, Bartos M, Sine SM, Bouzat C (2011) Functional relationships between agonist binding sites and coupling regions of homomeric Cys-loop receptors. J Neurosci 31: 3662-3669.
25. Holden-Dye L, Walker RJ (2007) Anthelmintic drugs. Available: http://www. wormbook.org/chapters/www-anthelminticdrugs/anthelminticdrugs.html. Accessed 2014 Mar 28.
26. Kass IS, Wang CC, Walrond JP, Stretton AO (1980) Avermectin B1a, a paralyzing anthelmintic that affects interneurons and inhibitory motoneurons in Ascaris. Proc Natl Acad Sci U S A 77: 6211-6215.
27. Jones AK, Rayes D, Al-Diwani A, Maynard TP, Jones R, et al. (2011) A Cysloop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function. J Biol Chem 286: 2550-2558.
28. Miltsch SM, Krucken J, Demeler J, Ramunke S, Harder A, et al. (2013) Interactions of anthelmintic drugs in Caenorhabditis elegans neuro-muscular ion channel mutants. Parasitol Int. 62:591-598.
29. Gally C, Bessereau JL (2003) GABA is dispensable for the formation of junctional GABA receptor clusters in Caenorhabditis elegans. J Neurosci 23: 2591-2599.
30. Kass IS, Stretton AO, Wang CC (1984) The effects of avermectin and drugs related to acetylcholine and 4-aminobutyric acid on neurotransmission in Ascaris suum. Mol Biochem Parasitol 13: 213-225.
31. Glendinning SK, Buckingham SD, Sattelle DB, Wonnacott S, Wolstenholme AJ (2011) Glutamate-gated chloride channels of Haemonchus contortus restore drug sensitivity to ivermectin resistant Caenorhabditis elegans. PLoS One 6: e22390.
32. Costa JL, Diazgranados JA (1994) Ivermectin for spasticity in spinal-cord injury. Lancet 343: 739.
33. Lloberas M, Alvarez L, Entrocasso C, Virkel G, Lanusse C, et al. (2012) Measurement of ivermectin concentrations in target worms and host gastrointestinal tissues: influence of the route of administration on the activity against resistant Haemonchus contortus in lambs. Exp Parasitol 131: 304-309.
34. Perez R, Cabezas I, Godoy C, Rubilar L, Munoz L, et al. (2002) Pharmacokinetics of doramectin and ivermectin after oral administration in horses. Vet J 163: 161-167.
35. Brown KR, Ricci FM, Ottesen EA (2000) Ivermectin: effectiveness in lymphatic filariasis. Parasitology 121 Suppl: S133-S146.
36. Dadarkar SS, Deore MD, Gatne MM (2007) Comparative evaluation of acute toxicity of ivermectin by two methods after single subcutaneous administration in rats. Regul Toxicol Pharmacol 47: 257-260.
37. Abdi Y.A., Gustafsson L.L., Ericsson O., and Hellgren U (1995) Handbook of drugs for tropical parasitic infections. London: Taylor & Francis Ltd, 4 John St, London WC1N 2ET.
38. Geary TG, Moreno Y (2012) Macrocyclic lactone anthelmintics: spectrum of activity and mechanism of action. Curr Pharm Biotechnol 13: 866-872.
39. Geary TG, Chibale K, Abegaz B, Andrae-Marobela K, Ubalijoro E (2012) A new approach for anthelmintic discovery for humans. Trends Parasitol 28: 176-181.
40. White JG, Southgate E, Thomson JN, Brenner S (1976) The structure of the ventral nerve cord of Caenorhabditis elegans. Philos Trans R Soc Lond B Biol Sci 275: 327-348.
41. Holden-Dye L, Krogsgaard-Larsen P, Nielsen L, Walker RJ (1989) GABA receptors on the somatic muscle cells of the parasitic nematode, Ascaris suum: stereoselectivity indicates similarity to a GABAA-type agonist recognition site. Br J Pharmacol 98: 841-850.
42. Martin RJ (1982) Electrophysiological effects of piperazine and diethylcarbamazine on Ascaris suum somatic muscle. Br J Pharmacol 77: 255-265.
43. Bamber BA, Twyman RE, Jorgensen EM (2003) Pharmacological characterization of the homomeric and heteromeric UNC-49 GABA receptors in C. elegans. Br J Pharmacol 138: 883-893.
44. Brown DD, Siddiqui SZ, Kaji MD, Forrester SG (2012) Pharmacological characterization of the Haemonchus contortus GABA-gated chloride channel, Hco-UNC-49: modulation by macrocyclic lactone anthelmintics and a receptor for piperazine. Vet Parasitol 185: 201-209.
45. Martin RJ (1985) Gamma-aminobutyric acid-and piperazine-activated singlechannel currents from Ascaris suum body muscle. Br J Pharmacol 84: 445-461.
46. Geary TG, Sims SM, Thomas EM, Vanover L, Davis JP, et al. (1993) Haemonchus contortus: ivermectin-induced paralysis of the pharynx. Exp Parasitol 77: 88-96.
47. Martin RJ (1996) An electrophysiological preparation of Ascaris suum pharyngeal muscle reveals a glutamate-gated chloride channel sensitive to the avermectin analogue, milbemycin D. Parasitology 112 (Pt 2): 247-252.
48. Geary TG (2005) Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol 21: 530-532.
49. Holden-Dye L, Walker RJ (1990) Avermectin and avermectin derivatives are antagonists at the 4-aminobutyric acid (GABA) receptor on the somatic muscle cells of Ascaris; is this the site of anthelmintic action? Parasitology 101 Pt 2: 265-271.
50. Menez C, Sutra JF, Prichard R, Lespine A (2012) Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis 6: e1883.
51. Lynagh T, Lynch JW (2012) Molecular mechanisms of Cys-loop ion channel receptor modulation by ivermectin. Front Mol Neurosci 5: 60.
52. Krause RM, Buisson B, Bertrand S, Corringer PJ, Galzi JL, et al. (1998) Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol Pharmacol 53: 283-294.
53. Raymond V, Mongan NP, Sattelle DB (2000) Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans. Neuroscience 101: 785-791.
54. Collins T, Millar NS (2010) Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Mol Pharmacol 78: 198-204.
55. Hibbs RE, Gouaux E (2011) Principles of activation and permeation in an anion-selective Cys-loop receptor. Nature 474: 54-60.
56. Wang Q, Lynch JW (2012) A comparison of glycine-and ivermectin-mediated conformational changes in the glycine receptor ligand-binding domain. Int J Biochem Cell Biol 44: 335-340.
57. Lynagh T, Webb TI, Dixon CL, Cromer BA, Lynch JW (2011) Molecular determinants of ivermectin sensitivity at the glycine receptor chloride channel. J Biol Chem 286: 43913-43924.
58. Sattelle DB, Buckingham SD, Akamatsu M, Matsuda K, Pienaar IS, et al. (2009) Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors. Biochem Pharmacol 78: 836-843.
59. Faghih R, Gfesser GA, Gopalakrishnan M (2007) Advances in the discovery of novel positive allosteric modulators of the alpha7 nicotinic acetylcholine receptor. Recent Pat CNS Drug Discov 2: 99-106.